Neurology Central

Honing in on hormone-sensitive neural targets for therapeutic intervention: mission impossible?

Stress-related neuropsychiatric disorders, such as depression and anxiety, are debilitating diseases that impose a great cost for patients, their families and society. Current first-line treatments for major depressive disorder and anxiety disorders target serotonergic neurotransmission, but the female-biased prevalence of these disorders has long suggested a role for hormones in the etiology and treatment of these diseases.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.